Sharing corporate and shareholder value through restricted stock compensation
First written in FY2021-Q1. 6 of 8 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2027-H1.
- FY2027-H1AdvancedAnnual report
「Eighth Series Stock Acquisition Rights (resolved by the Board of Directors on 18 May 2026)” “Categories and numbers of grantees (people): Company directors 1; Company employees 4” “Ninth Series Stock Acquisition Rights (resolved by the Board of Directors on 18 May 2026)” “Categories and numbers of grantees (people): Company directors 2”」
The Company established the Eighth and Ninth Series Stock Acquisition Rights for directors and employees, adding equity incentives for officers and employees. - FY2026AdvancedAnnual report
「Sixth Series Stock Acquisition Rights (resolved by the Board of Directors on 19 May 2025)” “Class, details and number of shares underlying the stock acquisition rights (shares): Common shares 32,800” “Seventh Series Stock Acquisition Rights (resolved by the Board of Directors on 19 May 2025)” “Class, details and number of shares underlying the stock acquisition rights (shares): Common shares 30,000”」
The Company disclosed equity incentives covering a total of 62,800 common shares under the Sixth and Seventh Series Stock Acquisition Rights resolved in May 2025. - FY2026-H1AdvancedAnnual report
「Sixth Series Stock Acquisition Rights (resolved by the Board of Directors on 19 May 2025)” “Categories and numbers of grantees (people): Company directors 1; Company employees 6” “Seventh Series Stock Acquisition Rights (resolved by the Board of Directors on 19 May 2025)” “Categories and numbers of grantees (people): Company directors 2”」
The Company established the Sixth and Seventh Series Stock Acquisition Rights for directors and employees, adding equity incentives for officers and employees. - FY2025ReframedAnnual report
「At the 15th Annual General Meeting of Shareholders held on 23 April 2025, the Company resolved to introduce restricted stock compensation for its directors, excluding directors who are Audit and Supervisory Committee members and outside directors, as a separate framework from the existing compensation and other benefits for directors. It also resolved that the total amount of monetary compensation claims for the allotment of restricted stock would be no more than ¥50 million per year.」
In addition to the existing restricted stock compensation plan, the Company introduced a new plan for directors excluding Audit and Supervisory Committee members and outside directors, with an annual limit of ¥50 million. - FY2024AdvancedAnnual report
「The Company resolved at a meeting of the Board of Directors held on 15 January 2024 to issue new shares as restricted stock, and payment procedures were completed on 5 February 2024.” “The Company's common shares: 9,000 shares” “Transfer restriction period: 5 February 2024 to the conclusion of the Annual General Meeting of Shareholders for the fiscal year ending January 2027」
The Company issued 9,000 common shares as restricted stock compensation and allotted them to directors and executive officers. The initiative to enhance medium- to long-term corporate and shareholder value and share value with shareholders progressed. - FY2022AdvancedAnnual report
「The purpose is to provide the Company's directors, executive officers and employees (collectively, the “Allottees”) with incentives to achieve sustained enhancement of the Company's medium- to long-term corporate and shareholder value, while promoting greater value sharing between the Allottees and shareholders.」
The Company issued 16,000 common shares on 1 March 2022 as restricted stock compensation and allotted them to directors, executive officers and employees. - FY2021-Q2AdvancedAnnual report
「18 June 2020 (Note 1) 20,500 (Note 1) Increase due to the issuance of new shares as restricted stock compensation. Issue price: ¥1,832 Amount credited to capital: ¥916 Allottees: 2 Company directors, 3 executive officers and 29 Company employees」
The Company issued 20,500 shares as restricted stock compensation and allotted them to 2 directors, 3 executive officers and 29 employees. - FY2021-Q1First statedAnnual report
「At a meeting of the Board of Directors held on 11 March 2020, the Company resolved to introduce a restricted stock compensation plan for its directors, excluding outside directors (the same applies below), as a new compensation plan, with the purpose of providing incentives for the sustained enhancement of the Company's medium- to long-term corporate value and shareholder value and promoting greater value sharing with shareholders. At the 10th Annual General Meeting of Shareholders held on 28 April 2020, approval was also obtained for the payment to the Company's directors of monetary compensation claims of up to ¥50 million per year, separate from the existing monetary compensation limit, as property contributed in kind for the issuance of restricted stock, and for the transfer restriction period for the restricted stock to be determined by the Board of Directors. Transfer restriction period: 18 June 2020 to the conclusion of the Annual General Meeting of Shareholders for the fiscal year ending January 2023」
The Company introduced a restricted stock compensation plan to enhance medium- to long-term corporate and shareholder value and share value with shareholders, setting compensation claims of up to ¥50 million per year and a transfer restriction period ending at the conclusion of the Annual General Meeting of Shareholders for the fiscal year ending January 2023.